[Interventional therapeutic strategies for metastatic liver cancer].

Q3 Medicine
X D Sun, L Jin
{"title":"[Interventional therapeutic strategies for metastatic liver cancer].","authors":"X D Sun, L Jin","doi":"10.3760/cma.j.cn501113-20260527-00209","DOIUrl":null,"url":null,"abstract":"<p><p>Metastatic liver cancer is a common terminal manifestation of malignant neoplasms, with colorectal cancer liver metastasis (CRLM) being particularly prevalent. Surgical resection is applicable only to a small proportion of patients. In recent years, interventional therapy has become an important local treatment modality for patients with unresectable metastatic liver cancer, offering advantages such as minimal invasiveness, precision, and repeatability, thus supporting downstaging, bridging, and salvage therapy. The role of interventional therapy is shifting from terminal palliative care toward a systematic therapeutic strategy within a multidisciplinary comprehensive management framework, emphasizing individualized stratification based on tumor burden, hepatic function, and therapeutic objectives to facilitate intrahepatic tumor burden reduction, create a window for radical treatment, and enhance long-term patient survival.</p>","PeriodicalId":24006,"journal":{"name":"中华肝脏病杂志","volume":"34 9","pages":"845-850"},"PeriodicalIF":0.0000,"publicationDate":"2026-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13616985/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华肝脏病杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn501113-20260527-00209","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Metastatic liver cancer is a common terminal manifestation of malignant neoplasms, with colorectal cancer liver metastasis (CRLM) being particularly prevalent. Surgical resection is applicable only to a small proportion of patients. In recent years, interventional therapy has become an important local treatment modality for patients with unresectable metastatic liver cancer, offering advantages such as minimal invasiveness, precision, and repeatability, thus supporting downstaging, bridging, and salvage therapy. The role of interventional therapy is shifting from terminal palliative care toward a systematic therapeutic strategy within a multidisciplinary comprehensive management framework, emphasizing individualized stratification based on tumor burden, hepatic function, and therapeutic objectives to facilitate intrahepatic tumor burden reduction, create a window for radical treatment, and enhance long-term patient survival.

转移性肝癌的介入治疗策略。
转移性肝癌是恶性肿瘤常见的终末表现,其中结直肠癌肝转移(CRLM)尤为普遍。手术切除只适用于一小部分患者。近年来,介入治疗已成为不可切除转移性肝癌患者的重要局部治疗方式,具有微创、精确、可重复性等优点,可支持降期、桥接和挽救治疗。介入治疗的作用正在从晚期姑息治疗转向多学科综合管理框架下的系统治疗策略,强调基于肿瘤负担、肝功能和治疗目标的个体化分层,以促进肝内肿瘤负担减轻,为根治性治疗创造窗口,提高患者的长期生存率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华肝脏病杂志
中华肝脏病杂志 Medicine-Medicine (all)
CiteScore
1.20
自引率
0.00%
发文量
7574
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书